Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 7
1951 1
1956 1
1958 2
1959 1
1966 1
1967 2
1968 5
1969 1
1974 2
1975 1
1976 1
1977 2
1978 1
1981 1
1984 1
1986 1
1987 2
1988 1
1989 1
1990 1
1992 1
1999 1
2002 1
2003 2
2004 1
2005 3
2006 2
2007 8
2008 11
2009 10
2010 13
2011 17
2012 26
2013 31
2014 34
2015 17
2016 22
2017 30
2018 21
2019 24
2020 45
2021 40
2022 40
2023 57
2024 38
2025 53

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

523 results

Results by year

Filters applied: . Clear all
Page 1
Antidepressant discontinuation syndrome: A state-of-the-art clinical review.
Fornaro M, Cattaneo CI, De Berardis D, Ressico FV, Martinotti G, Vieta E. Fornaro M, et al. Among authors: martinotti g. Eur Neuropsychopharmacol. 2023 Jan;66:1-10. doi: 10.1016/j.euroneuro.2022.10.005. Epub 2022 Nov 4. Eur Neuropsychopharmacol. 2023. PMID: 36345093 Free article. Review.
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead.
Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, Del Felice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G, McDonald WM, Montemitro C, Nakamura-Palacios EM, Nasehi M, Noël X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, Salmeron BJ, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan TF, van Dongen JDM, Van Waes V, Venkatasubramanian G, Verdejo-García A, Verveer I, Welsh JW, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast MR, Zawertailo L, Zhang X, Cha YH, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA. Ekhtiari H, et al. Among authors: martinotti g. Neurosci Biobehav Rev. 2019 Sep;104:118-140. doi: 10.1016/j.neubiorev.2019.06.007. Epub 2019 Jul 2. Neurosci Biobehav Rev. 2019. PMID: 31271802 Free PMC article.
Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus group.
Palagini L, Brugnoli R, Dell' Osso BM, Di Nicola M, Maina G, Martinotti G, Maruani J, Mauries S, Serafini G, Mencacci C, Liguori C, Ferini-Strambi L, Geoffroy PA, Balestrieri M. Palagini L, et al. Among authors: martinotti g. Sleep Med. 2025 Apr;128:117-126. doi: 10.1016/j.sleep.2025.01.033. Epub 2025 Jan 31. Sleep Med. 2025. PMID: 39923608
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study).
Martinotti G, Vita A, Fagiolini A, Maina G, Bertolino A, Dell'Osso B, Siracusano A, Clerici M, Bellomo A, Sani G, d'Andrea G, Chiaie RD, Conca A, Barlati S, Di Lorenzo G, De Fazio P, De Filippis S, Nicolò G, Rosso G, Valchera A, Nucifora D, Di Mauro S, Bassetti R, Martiadis V, Olivola M, Belletti S, Andriola I, Di Nicola M, Pettorruso M, McIntyre RS, di Giannantonio M; REAL-ESK Study Group. Martinotti G, et al. J Affect Disord. 2022 Dec 15;319:646-654. doi: 10.1016/j.jad.2022.09.043. Epub 2022 Sep 24. J Affect Disord. 2022. PMID: 36167246
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
Guirguis A, Chiappini S, Papanti P GD, Vickers-Smith R, Harris D, Corkery JM, Arillotta D, Floresta G, Martinotti G, Schifano F. Guirguis A, et al. Among authors: martinotti g. Eur Neuropsychopharmacol. 2024 May;82:82-91. doi: 10.1016/j.euroneuro.2024.02.003. Epub 2024 Mar 19. Eur Neuropsychopharmacol. 2024. PMID: 38508100 Free article.
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C, Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Martinotti G, et al. Bipolar Disord. 2023 May;25(3):233-244. doi: 10.1111/bdi.13296. Epub 2023 Jan 18. Bipolar Disord. 2023. PMID: 36636839 Free article.
523 results